Get the Stockscreener App
1.43
2.72%
-0.04
Pre-market:
1.48
0.05
+3.50%
Bioaffinity Technologies Inc stock is traded at $1.43, with a volume of 61,595.
It is down -2.72% in the last 24 hours and down -46.04% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$1.47
Open:
$1.53
24h Volume:
61,595
Relative Volume:
0.02
Market Cap:
$6.43M
Revenue:
$9.37M
Net Income/Loss:
$-8.45M
P/E Ratio:
-1.7654
EPS:
-0.81
Net Cash Flow:
$-7.27M
1W Performance:
-9.49%
1M Performance:
-46.04%
6M Performance:
-81.80%
1Y Performance:
-96.09%
1-Day Range:
$1.415
$1.53
1-Week Range:
$1.25
$1.58
52-Week Range:
$1.25
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.43 | 6.61M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
Earnings roundup: Q3 rocky for bioAffinity and Spurs concessionaire - San Antonio Express-News
Is bioAffinity Technologies Inc Equity Warrant a good long term investmentMean Reversion Trades & Rapid Portfolio Gain - earlytimes.in
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies Reports Surge in CyPath® Lung Tests - MSN
bioAffinity Technologies Reports Strong Growth in Lung Test Revenue - MSN
How bioAffinity Technologies Inc. stock benefits from tech adoptionJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Is bioAffinity Technologies Inc. stock cheap compared to fundamentalsTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
Will bioAffinity Technologies Inc. stock deliver strong dividend growthWeekly Volume Report & Real-Time Market Sentiment Reports - newser.com
Will bioAffinity Technologies Inc. stock recover faster than marketJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
Is bioAffinity Technologies Inc. stock a buy for dividend growth2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Volume spikes in bioAffinity Technologies Inc. Equity Warrant stock – what they mean2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is bioAffinity Technologies Inc. meeting your algorithmic filter criteriaProduct Launch & Fast Exit and Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock oversold or undervaluedTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Maxim Group Sticks to Its Buy Rating for bioAffinity Technologies, Inc. (BIAF) - The Globe and Mail
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trendsPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Why bioAffinity Technologies Inc. stock is seen as undervalued2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Will bioAffinity Technologies Inc. stock see insider buying2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
What recovery options are there for bioAffinity Technologies Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Using data filters to optimize entry into bioAffinity Technologies Inc. Equity WarrantJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
MSN Money - MSN
Is bioAffinity Technologies Inc. stock attractive for growth ETFs2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Can momentum traders help lift bioAffinity Technologies Inc. Equity WarrantMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform Dow Jones indexMarket Activity Report & High Accuracy Investment Signals - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock beat EPS estimatesMarket Performance Summary & Risk Managed Trade Strategies - newser.com
Can volume confirm reversal in bioAffinity Technologies Inc.July 2025 Institutional & Intraday High Probability Alerts - newser.com
BioAffinity Technologies Reports Third Quarter 2025 Financial Results - MarketScreener
Published on: 2025-11-17 03:00:15 - newser.com
Can bioAffinity Technologies Inc. stock resist sector downturnsJuly 2025 Rallies & Intraday High Probability Alerts - newser.com
bioAffinity Technologies Reports Third Quarter 2025 Financial Results - BioSpace
How institutional buying supports bioAffinity Technologies Inc. Equity Warrant stockRate Cut & Safe Entry Point Identification - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform value stocksJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
What to do if you’re stuck in bioAffinity Technologies Inc. Equity WarrantMarket Performance Recap & Stock Portfolio Risk Management - newser.com
Is a relief rally coming for bioAffinity Technologies Inc. holders2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
Sector ETF performance correlation with bioAffinity Technologies Inc.July 2025 Weekly Recap & Weekly Momentum Picks - newser.com
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):